The CAPP II trial of aspirin in Lynch syndrome/HNPCC: is it time for everyone to be treated?

Patrick M Lynch

Published in: Familial cancer (2021)

Keyphrases

low dose
study protocol
phase iii
clinical trial
phase ii
cardiovascular events
case report
antiplatelet therapy
randomized controlled trial
type diabetes
newly diagnosed
cardiovascular disease
coronary artery disease
percutaneous coronary intervention
anti inflammatory drugs